Oppenheimer & Co. Inc. cut its holdings in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) by 18.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,840 shares of the semiconductor company’s stock after selling 405 shares during the period. Oppenheimer & Co. Inc.’s holdings in Lam Research were worth $1,502,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently modified their holdings of LRCX. CarsonAllaria Wealth Management Ltd. acquired a new stake in Lam Research during the 2nd quarter worth approximately $32,000. RFP Financial Group LLC increased its stake in Lam Research by 52.2% in the 2nd quarter. RFP Financial Group LLC now owns 35 shares of the semiconductor company’s stock valued at $37,000 after buying an additional 12 shares during the last quarter. Hobbs Group Advisors LLC bought a new stake in shares of Lam Research during the 2nd quarter worth approximately $40,000. Country Trust Bank acquired a new position in Lam Research during the second quarter worth $43,000. Finally, MFA Wealth Advisors LLC bought a new stake in Lam Research during the second quarter worth $45,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Insider Activity at Lam Research
In other news, CAO Christina Correia sold 647 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $817.51, for a total value of $528,928.97. Following the transaction, the chief accounting officer now owns 4,267 shares in the company, valued at approximately $3,488,315.17. This trade represents a 13.17 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.29% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on Lam Research
Lam Research Trading Down 6.3 %
Shares of Lam Research stock opened at $70.05 on Monday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 1.74. Lam Research Co. has a 1 year low of $68.72 and a 1 year high of $113.00. The firm has a market cap of $90.13 billion, a PE ratio of 22.64, a PEG ratio of 1.11 and a beta of 1.48. The company has a 50 day simple moving average of $77.23 and a two-hundred day simple moving average of $87.95.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.81 by $0.05. The company had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $4.06 billion. Lam Research had a net margin of 26.02% and a return on equity of 50.60%. The firm’s revenue was up 19.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.85 EPS. Analysts expect that Lam Research Co. will post 3.52 earnings per share for the current fiscal year.
Lam Research Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 8th. Investors of record on Wednesday, December 11th will be given a $0.23 dividend. The ex-dividend date is Wednesday, December 11th. This represents a $0.92 dividend on an annualized basis and a yield of 1.31%. Lam Research’s payout ratio is 29.74%.
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading
- Five stocks we like better than Lam Research
- What is the Shanghai Stock Exchange Composite Index?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Best Aerospace Stocks Investing
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Are Dividend Challengers?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.